Sunil Healthcare Ltd Q4 FY26 Results

Summary

Sunil Healthcare Ltd. reported a consolidated revenue from operations of ₹8,771.92 Lakhs for the financial year ended March 31, 2026, marking a 5.15% increase year-over-year. The company achieved a significant turnaround in profitability, posting a consolidated Profit After Tax of ₹400.60 Lakhs for FY26, compared to a loss of ₹141.66 Lakhs in the prior year. For the fourth quarter of FY26, consolidated revenue stood at ₹1,972.23 Lakhs, experiencing a 7.08% decline year-on-year, though Q4 PAT improved substantially by 316.33% to ₹151.61 Lakhs. The consolidated EBITDA margin for the full year reached 17.04%. The Board did not recommend a dividend for FY26.

Key Highlights

1. 1

   Consolidated revenue from operations for the financial year ended March 31, 2026, increased by 5.15% to ₹8,771.92 Lakhs.

2. 2

   The company reported a significant turnaround in consolidated Profit After Tax (PAT) for FY26, achieving ₹400.60 Lakhs compared to a loss of ₹141.66 Lakhs in the previous fiscal year.

3. 3

   Consolidated revenue from operations for the fourth quarter of FY26 stood at ₹1,972.23 Lakhs, representing a decline of 7.08% year-over-year.

4. 4

   Q4 FY26 consolidated Profit After Tax (PAT) showed substantial growth, rising by 316.33% year-over-year to ₹151.61 Lakhs.

5. 5

   The consolidated EBITDA margin for the full financial year 2026 improved to 17.04%.

6. 6

   The Board of Directors has not recommended any payment of dividend to the Members of the Company for the financial year 2025-26.

7. 7

   M/s. Agrawal S. Lal & Co., Chartered Accountants, were approved as Internal Auditors for Financial Year 2026-27.